معرفی
Dr. Urszula Masiukiewicz is a Clinical Assistant Professor of Medicine at Yale School of Medicine (part-time) and a Senior Director in the Cardiovascular and Metabolic Division at Pfizer. She holds an MD from Warsaw University (1985) and completed postgraduate training at the National Institute of Cardiology (Warsaw) and internal medicine residency at the University of Massachusetts-Memorial Medical Center. Her clinical and research interests focus on postmenopausal osteoporosis, calcium metabolism disorders, metabolic bone diseases, and thyroid diseases. She has conducted clinical research at Pfizer since 2004, bridging academia and industry.
Research Highlights: Dr. Masiukiewicz’s work spans endocrinology, bone metabolism, and drug efficacy evaluation. Key areas include the role of cytokines in bone remodeling, cardiovascular outcomes of novel therapies (e.g., Ertugliflozin), and pediatric anticoagulation strategies. Her studies often involve large-scale clinical trials (e.g., VERTIS-CV) and translational research linking basic cytokine biology to clinical outcomes.
- Awards:
- Young Investigator Award (ASBMR, 2000)
- Endocrine Fellows Foundation Research Award (1998)
- NIH NIDDK Clinical Scientist Award (1998)
- Key Collaborations: Works with Karl Insogna, Barbara Gulanski, and James Revkin on bone metabolism and endocrine disorders.
- Labs/Teams: Affiliated with Yale’s Bone Center and Endocrinology Department; leads clinical trials at Pfizer.
Her research emphasizes bridging clinical and molecular insights, particularly in osteoporosis and metabolic bone diseases. Recent work evaluates cardiovascular and renal outcomes of diabetes therapies, reflecting her dual focus on endocrine and cardiovascular health.
